Left Axillary Implantation of Loop Recorder versus the Traditional Left Chest Area: A Prospective Randomized Study.

Background: Based upon the results of a previous small pilot study, we present the results of a prospective single-center randomized study comparing the performance of the implantable loop recorder (ILR) at two implanting sites.

Methods: A group of patients whose ILRs were implanted via a left axillary approach were compared with a group who received an ILR in the traditional left site of the chest. Follow-up (FU) was scheduled every 6 months or when symptoms occurred.

Left axillary implantation of loop recorder.

Background: We compared the clinical course of 10 patients who received an implantable loop recorder (ILR) at a traditional site with 11 patients whose ILRs were implanted via a subpectoral site via a left axillary approach without complications.

Methods And Results: R-wave amplitude was determined at implantation and during follow-up. Each patient was followed after 7 days to optimize device setting and then at 1 and 3 months.

VDD pacemaker replacement is safe and reliable independently of the previously implanted lead: a prospective and controlled study.

Unlabelled: Theoretically, replacement of a VDD device requires using a similar pacemaker to provide the best match between the filtering characteristics of the pacemaker and the atrial dipole of the lead. This study evaluated the performance of newly implanted Vitatron VDD pacemakers connected to dedicated leads and compared the results with those of the same Vitatron pacemakers used as replacement but connected to a variety of nondedicated leads.

Methods: 23 consecutive patients (15 M, 8 F, 78 +/- 6 years) in Group 1 underwent pacemaker replacement with a VDD(R) Saphir 3 (Vitatron BV, Arnhem, The Netherlands) device designed for an 8.

Heart rate regularisation in patients with permanent atrial fibrillation implanted with a VVI(R) pacemaker.

Unlabelled: Irregularity of ventricular cycles is a cause of haemodynamic impairment and symptoms in patients with atrial fibrillation (AF).

Aim Of The Study: Aim of the study was to determine the optimal pacing rate to stabilise ventricular cycle length at rest in patients with chronic AF, bradycardiac symptoms and VVI pacing.

Methods: The compensatory pause (CP) in AF, as defined by Langendorf, was used as a reference value in pacing the heart.

VDD pacemaker replacement independently of the implanted lead: a prospective study.

Background: Single-lead VDD pacing is effective, safe and reliable. The only still open, practical issue is represented by the theoretical need of replacing each device with a similar one compatible with the already implanted lead to guarantee the performance of the system. The aim of our study was to investigate the atrial sensing performance of VDD pacemakers working in combination with non-dedicated chronic leads.